Since FLJ10261 (ANO1) was characterized using bioinformatics as a gene residing between FGF3 and FADD genes at 11q13 28, the genes including ANO1 amplified in the 11q13 core region were considered as markers of cancers. The gene discussed is ANO1; the disease is cancer.